Two Sigma Securities’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Two Sigma Securities’s Portfolio VCNX Stock Details VCNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-154	Closed	-$12.9K	–	3472
2023 Q1	$12.9K	Buy	+154	New	+$16.9K	﹤0.01%	2424
2022 Q3	–	Sell	-260	Closed	-$59K	–	3214
2022 Q2	$59K	Buy	260 +180	+225%	+$46K	﹤0.01%	1829
2022 Q1	$22K	Buy	+80	New	+$22.1K	﹤0.01%	1967

Other funds holding VCNX

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Two Sigma Securities's VCNX Position: Q2 2023 in Review

Two Sigma Securities sold out of Vaccinex, Inc. Common Stock (VCNX) in Q2 2023, closing a stake of 154 shares — an estimated $12.9K sold.

Two Sigma Securities first reported a position in VCNX in Q1 2022 and held it in 3 quarters. The position peaked at $59K in Q2 2022. 22 funds tracked by Wall St. Rank hold VCNX as of Q2 2023.

Two Sigma Securities reported no remaining Vaccinex, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Two Sigma Securities sold 154 Vaccinex, Inc. Common Stock shares in Q2 2023, an estimated $12.9K.
Two Sigma Securities first reported a position in Vaccinex, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
Two Sigma Securities's Vaccinex, Inc. Common Stock position peaked at $59K in Q2 2022.
22 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q2 2023.

Based on Two Sigma Securities's 13F filing for Q2 2023, filed 14 Aug 2023.